GI
IPSC icon

GAMMA Investing’s Century Therapeutics IPSC Stock Holding History

GAMMA Investing’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-131
Closed -$224 – 3804
2024
Q3 		$224 Sell
131
-45
-26% -$88 ﹤0.01% 3483
2024
Q2 		$449 Sell
176
-119
-40% -$376 ﹤0.01% 3226
2024
Q1 		$1.23K Buy
295
+119
+68% +$504 ﹤0.01% 2897
2023
Q4 		$753 Buy
+176
New +$321 ﹤0.01% 2872

Other funds holding IPSC

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

GAMMA Investing's IPSC Position: Q4 2024 in Review

GAMMA Investing sold out of Century Therapeutics (IPSC) in Q4 2024, closing a stake of 131 shares — an estimated $224 sold.

GAMMA Investing first reported a position in IPSC in Q4 2023 and held it in 4 quarters. The position peaked at $1.23K in Q1 2024. 72 funds tracked by Wall St. Rank hold IPSC as of Q4 2024.

  • GAMMA Investing reported no remaining Century Therapeutics position as of Q4 2024 after selling out during the quarter.
  • GAMMA Investing sold 131 Century Therapeutics shares in Q4 2024, an estimated $224.
  • GAMMA Investing first reported a position in Century Therapeutics in Q4 2023 and held it in 4 quarters.
  • GAMMA Investing's Century Therapeutics position peaked at $1.23K in Q1 2024.
  • 72 funds tracked by Wall St. Rank held Century Therapeutics as of Q4 2024.

Based on GAMMA Investing's 13F filing for Q4 2024, filed 3 Jan 2025.